Boothbay Fund Management, LLC Bicycle Therapeutics PLC Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$20.02 - $31.37 $802,802 - $1.26 Million
40,100 New
40,100 $852,000
Q2 2022

Aug 15, 2022
SELL
$12.95 - $46.99 $416,990 - $1.51 Million
-32,200 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$40.12 - $59.5 $770,304 - $1.14 Million
19,200 Added 147.69%
32,200 $1.41 Million
Q3 2021

Nov 15, 2021
BUY
$27.95 - $44.24 $363,350 - $575,120
13,000 New
13,000 $541,000

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.7M
Call Options Held
3.4K
Put Options Held
12.4K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $674M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email